Rapid HIV Test Donation Program

Partnership objectives

  1. Provide access to rapid HIV-tests to identify and refer to treatment pregnant women who are HIV-positive and reduce transmission of the virus to the child. 
  2. AbbVie Foundation is part of an international effort to help reducing the new pediatric HIV infection rate, by undertaking PMTCT and bringing the transmission of the HIV virus to the child rate to less than 5% by the end of 2015. 

Between 2002-2013, more than 24 million rapid HIV tests have been distributed through the HIV Rapid Test Donation Program. Between 2002-2013, more than 24 million rapid HIV tests have been distributed through the HIV Rapid Test Donation Program. Copyright Direct Relief

What are the health needs and challenges?

Each year, approximately 430,000 babies around the world become infected with HIV during their mothers' pregnancy, during birth or through breastfeeding. Enabling pregnant women to know their HIV status before they give birth is the first step in preventing mother-to-child transmission (PMTCT) of HIV. However, for many pregnant women living in the developing world, testing is limited because of cost, time required to receive results, and lack of trained health care staff and testing facilities.

 Description of partnership activities and how they address needs and challenges

Rapid on-site testing can have a significant impact in the fight against HIV/AIDS. Using a small amount of whole blood, serum or plasma, any program in a remote setting can obtain results regardless of access to laboratory equipment or electricity. To facilitate access to rapid HIV testing, in 2002 Abbott made a commitment to donate rapid (15 minute) HIV tests to PMTCT programs in all of Africa and the Least Developed Countries, as defined by the United Nations. In 2013, the HIV Rapid Test Donation Program became part of the AbbVie Foundation.

The program has also extended its PMTCT donations to include testing of spouses and children of pregnant women who are found to be HIV positive through the program.

Summary of impact and forward looking information

To date, more than 27 million rapid HIV tests have been donated. This program has historically been in 33 countries and it now operating in 45. It is estimated that a minimum of 150,000 cases of HIV have been averted in infants over the past twelve years by conducting this program.  

Partnership information

Company(ies) AbbVie

Partner(s) Direct Relief

Type of Partner(s) NGOs

Therapeutic Focus Infectious Diseases

Disease(s) HIV/AIDS

Program Type(s) Availability of Treatment - Product Donations

Targeted Population(s) Men, Mothers, Patients in needs of treatment, People with low income, Women

Region(s) Europe & Central Asia, Latin America & Caribbean, South Asia, Sub-Saharan Africa

Number of Countries 34

Country(ies) Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Côte d'Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, Ghana, Guinea, Haiti, Kenya, Lesotho, Liberia, Malawi, Mali, Mozambique, Nepal, Nigeria, Romania, Rwanda, Senegal, Sierra Leone, South Africa, South Sudan, Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia, Zimbabwe

Start Date 2002

More information HIV Rapid Test Donation Program

Anticipated completion date Ongoing